Interestingly, SLFN11 sensitizes RKO, DLD1, and SW620 colorectal cancer cells to cisplatin and reduces in vivo tumor growth in mice [22], suggesting a favorable role for SLFN11 in CRC. This evidence concerns the gene SLFN11 and colorectal cancer.